Plasma D-dimer and severity in adult community-acquired pneumonia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will enroll at least 50 adults with community-acquired pneumonia seen or admitted to Ain Shams University Hospitals in Cairo. Investigators will collect blood for plasma D-dimer and routine labs (white blood cell count, CRP), obtain chest x-rays, and calculate CURB-65 severity scores. The analysis will examine relationships between D-dimer levels, markers of inflammatory response, clinical severity scores, and survival. Patients with coagulation disorders, active cancer, other chronic diseases, or signs of COVID-19 will be excluded and no experimental treatments are administered.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients who will be admitted to the Chest department, or coming to the outpatient clinic at Ain-Shams University Hospitals with CAP, and have the following inclusions:

  1. age ≥18 years
  2. diagnosis of CAP based on clinical symptoms, laboratory findings, and radiological evidence.

Exclusion Criteria:

* Patients with a history of coagulation disorders, cancer, or other chronic diseases, or refusal to participate.
* patients who have any clinical or radiological signs suggesting COVID-19 pneumonia.

Where it's running

• Ain Shams University hospitals
  Cairo, Egypt Recruiting

Study contacts

• Study coordinator: Hieba Gamal Ezzelregal
• Email: hiebagamal24@med.asu.edu.eg
• Phone: +201002041611

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• New tool for diagnosing pulmonary embolism in emergency departments

  This study is testing a new tool to help emergency doctors decide when imaging for pulmonary embolism is really needed, aiming to reduce unnecessary scans and radiation exposure for patients.

  Recruiting at 2 sites Queen's University · Hamilton, Ontario and 3 other locations · NCT06320236

• Identifying New Cancer After Ischemic Stroke in High-Risk Patients

  This study is trying to see if people who had an ischemic stroke and have high D-dimer levels are more likely to be diagnosed with hidden cancer within a year.

  Recruiting at 3 sites Insel Gruppe AG, University Hospital Bern · Lausanne, Canton of Vaud and 2 other locations · NCT06100718

• NAVA use in preterm neonates with respiratory distress syndrome

  This trial tests whether neurally adjusted ventilatory assist (NAVA) helps preterm babies with respiratory distress syndrome breathe more easily than conventional ventilation.

  Recruiting Ain Shams University · Cairo, Abbasia · NCT07926009

• Ruta C and Vitamin C in Sepsis: Adding antioxidants to standard care

  This trial tests whether adding Ruta C (rutin plus vitamin C) or vitamin C alone to standard sepsis treatment helps adults in the ICU stay shorter and recover better.

  Recruiting Ain Shams University · Cairo, Cairo Governorate · NCT07922213

• Left DLPFC rTMS vs iTBS for emotional dysregulation, impulsivity, and NSSI in Borderline Personality Disorder

  This trial tests whether high-frequency rTMS or intermittent theta-burst stimulation over the left DLPFC can help reduce emotional instability, impulsivity, and non-suicidal self-injury in adults with Borderline Personality Disorder.

  Recruiting Ain Shams University · Cairo, Cairo Governorate · NCT07919587

• Trimetazidine as an extra therapy for aluminum phosphide poisoning

  In this pilot trial, adults with acute aluminum phosphide poisoning receive standard care plus trimetazidine to see if it helps save lives and improve recovery.

  Recruiting Phase 3 Ain Shams University · Cairo, Abbassia · NCT07916922

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.